RecruitingNot ApplicableNCT07485075

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

SBI 2024-2026 STENO FOOD CONCEPT


Sponsor

Steno Diabetes Center Copenhagen

Enrollment

104 participants

Start Date

Mar 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).


Eligibility

Min Age: 18 YearsMax Age: 74 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called StenoFood App for people with diabetes type 2 and kidney disease. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 74 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEStenoFood App

Digital patient education program (app-based) with dietary guidance and self-monitoring tools


Locations(2)

Steno Diabetes Center Copenhagen,

Herlev, Captial Region of Denmark, Denmark

Nordsjællands Hospital, Hillerød

Hillerød, Captial Region of Denmark, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07485075


Related Trials